Oncology

肿瘤科 · Nanjing Second Hospital, Nanjing

Established in 1994, this department specializes in the standardized treatment of mid-to-late stage solid tumors. The team provides systemic and local chemotherapy, molecular targeted therapy, and biological treatments for conditions including lung, breast, gastric, colorectal, esophageal, and liver cancers. For liver cancer, the department combines hepatic artery chemoembolization, microwave ablation, and alcohol injection with systemic chemotherapy. Additional services include supportive care for advanced tumors, metal stent placement for obstructions, and photodynamic therapy. The department aims to improve patient quality of life through integrated domestic and international clinical research protocols.

Conditions and treatments

Key facts

Rewritten in English from the department's own description on a public doctor-listing platform. Claims such as "leading" are the hospital's own.

SpecialtyMedical Oncology
Doctors listed21
Chief physicians6

Senior doctors

Chief and associate chief physicians listed for this department on public doctor-listing platforms (2025–2026).

Chief physicians

Associate chief physicians

We are an independent coordination service, not part of this hospital. Names and titles change; the hospital's website is the final word. How we build this directory.

Need a specialist's opinion?

Send your records and question. We find a specialist in the right field who reviews your case and tells you what they recommend.

Contact us